Brevican (BCAN) (Middle Region) Peptide
BCAN
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BCAN products
- BCAN (Brevican (BCAN))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ESLSQAPARA VLQPGASPLP DGESEASRPP RVHGPPTETL PTPRERNLAS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- BCAN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAN (Brevican (BCAN))
- Synonyms
- fi32a12 Peptide, wu:fi32a12 Peptide, BCAN Peptide, Xbcan Peptide, Cspg7 Peptide, ALPBRE Peptide, BEHAB Peptide, CSPG7 Peptide, brevican Peptide, brevican L homeolog Peptide, bcan Peptide, BCAN Peptide, bcan.L Peptide, Bcan Peptide
- Background
-
This gene encodes a member of the lectican family of chondroitin sulfate proteoglycans that is specifically expressed in the central nervous system. This protein is developmentally regulated and may function in the formation of the brain extracellular matrix. This protein is highly expressed in gliomas and may promote the growth and cell motility of brain tumor cells. Alternate splicing results in multiple transcript variants.
Alias Symbols: BEHAB, CSPG7
Protein Size: 671 - Gene ID
- 63827
- NCBI Accession
- NM_021948, NP_068767
-
You are here:
